[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356096-105":59,"doc-detail-356096-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","whole-exome-sequencing-revealed-rare-variants-in-brca2-rad51d-fangc-cyp24a1-genes-in-breastovarian-cancer-patients","Whole Exome Sequencing Revealed Rare Variants in BRCA2, RAD51D, FANGC, CYP24A1 Genes in Breast/Ovarian Cancer Patients","","Breast cancer continues to rise in incidence, prevalence, and mortality worldwide, and germline DNA repair variants in BRCA1/2 are central to hereditary breast/ovarian cancer risk. Many geographically isolated ethnic groups, however, remain without identified founder variants. This study reports whole exome sequencing of 56 Buryat patients, identifying likely pathogenic/pathogenic variants in 16%, including recurrent RAD51D c.757C>T.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/whole-exome-sequencing-revealed-rare-variants-in-brca2-rad51d-fangc-cyp24a1-genes-in-breastovarian-cancer-patients/356096/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/whole-exome-sequencing-revealed-rare-variants-in-brca2-rad51d-fangc-cyp24a1-genes-in-breastovarian-cancer-patients/356096.png","ImageObject",300,407,{"name":92,"@type":93},"RuangKosong","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main objective of the study?","Question",{"text":113,"@type":114},"To identify rare germline variants associated with hereditary breast/ovarian cancer in a small Buryat ethnic group using whole exome sequencing data.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How many Buryat patients were included and what data were collected?",{"text":118,"@type":114},"The study included 56 Buryat patients with histologically confirmed primary breast/ovarian cancer and collected basic information and nationality via an anonymous questionnaire.",{"name":120,"@type":111,"acceptedAnswer":121},"Which genes and variants were reported as likely pathogenic/pathogenic?",{"text":122,"@type":114},"Likely pathogenic/pathogenic variants were detected in genes including BRCA2, RAD51D, FANCG and others mentioned, with three rare germinal BRCA2 variants and a recurrent RAD51D variant c.757C>T observed in 4% of patients.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},356096,1790148819,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":46,"preview_page_count":19,"preview_urls":145},962090883219,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","RESEARCH ARTICLE  \n\n| Editorial Proc | ess: Submission:07/17/2025 Acceptance:02/01/2026 Published:02/05/2026 |\n| --- | --- |\n\nWhole Exome Sequencing Revealed Rare Variants in BRCA2, RAD51D, FANGC, CYP24A1 Genes in Breast/Ovarian Cancer Patients from a Small Buryat Ethnic Group  \nPolina Gervas1,2*, Alexey Molokov1, Nataliya Babyshkina1, Anna Ivanova1, Olesya Kollantay1, Michail Buldakov1, Liliya Molonova3, Alexey Zarubin4, Evgeny Choynzonov1, Nadezda Cherdyntseva1  \nAbstract  \nObjective: Breast cancer is a public health problem with increasing incidence, prevalence, and mortality worldwide. Germline variants in the DNA repair genes BRCA1/2 are involved in the pathogenesis of hereditary breast/ovarian cancer. However, for many ethnic groups that are isolated geographically worldwide, founder variants of breast cancer still have not been found. In this study, we provide whole exome sequencing data performed in a group of breast/ovarian cancer patients who belong to the Buryats. Methods: Our study included 56 Buryat patients with histologically confirmed primary breast/ovarian cancer who completed an anonymous questionnaire about basic information and nationality. Genomic DNA was isolated from peripheral blood leukocytes. Libraries were prepared using a BGI Optimal DNA Library Prep kit (MGI, China). AnAgilent SureSelect Human All Exon V6 kit (Agilent, USA) was used for hybridization. High-throughput sequencing was performed on a DNA nanoball sequencing platform DNBSeq-G400 (MGI, China) . Result: In the overall group of patients with signs of hereditary breast/ovarian cancer, likely pathogenic/pathogenic variants were detected in 16%(9/56). We have discovered likely pathogenic/pathogenic variants that can either directly (BRCA2, RAD51D, FANCG) or indirectly (POLR2C, FOXL2, GDF9, CYP21A4) initiate breast/ovarian cancer. For the first time, three rare germinal variants in the BRCA2 gene were detected in a small Buryat ethnic group. Further studies are required to confirm their role in the pathogenesis of breast /ovarian cancer in this ethnic group. We found that the RAD51D gene variant c.757C>T is recurrent and was observed in 4% of Buryat patients with breast/ovarian cancer. Conclusion: For the first time, rare germinal variants in the BRCA2, RAD51D, FANGC, CYP24A1 genes were detected in a small Buryat ethnic group. Our data are consistent with existing data showing that variants in the RAD51D gene may be involved in the pathogenesis of breast/ovarian cancer. We also showed that the Mongolic-speaking Buryat populations exhibited strong genetic resemblance to those of Chinese.  \nKeywords: Germline variants-breast cancer-ethnic groups-Buryat-non-Caucasian  \nAsian Pac J Cancer Prev, 27 (2), 651-658  \nIntroduction  \nBreast cancer is a public health problem with increasing incidence, prevalence and mortality worldwide [1]. Germline variants in the DNA repair genes BRCA1/2 are involved in the pathogenesis of breast/ovarian cancer. The presence of these variants may lead to the manifestation of the hereditary breast/ovarian cancer syndrome at a young age. The BRCA1/2 founder effect or the accumulation of certain variants in these genes has been described for some populations. These populations are known as genetic isolates due to their cultural or  \ngeographic isolation over many generations, either by preference for conservation culture and/or religion, or by geographical or societal restrictions [2] . The detection of BRCA1/2 founder variants allows for more efficient and cost-effective genetic testing and cancer prevention strategies in populations where these variants are prevalent. By focusing on a smaller set of variants, testing becomes more rapid and affordable. This allows for early detection and preventive measures for high-risk individuals, potentially preventing the development of breast and ovarian cancers.  \nHowever, for many ethnic groups isolated  \n1Department of Cancer Research, Cancer Research Institute, Tomsk National Re","cbCaisWQpejlzdj4","https://ap.wps.com/l/cbCaisWQpejlzdj4","pdf",1169575,"English","# Introduction\n# Materials and Methods\n# Results\n# Conclusion","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To identify rare germline variants associated with hereditary breast/ovarian cancer in a small Buryat ethnic group using whole exome sequencing data.\"},{\"question\":\"How many Buryat patients were included and what data were collected?\",\"answer\":\"The study included 56 Buryat patients with histologically confirmed primary breast/ovarian cancer and collected basic information and nationality via an anonymous questionnaire.\"},{\"question\":\"Which genes and variants were reported as likely pathogenic/pathogenic?\",\"answer\":\"Likely pathogenic/pathogenic variants were detected in genes including BRCA2, RAD51D, FANCG and others mentioned, with three rare germinal BRCA2 variants and a recurrent RAD51D variant c.757C\\u003eT observed in 4% of patients.\"}]","Whole Exome Sequencing Revealed Rare Variants in BRCA2, RAD51D, FANGC, CYP24A1 Genes in Breast/Ovarian Cancer Patients | PDF",1790123368,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c421a880cce7c6114cb829682c3be8ea.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a03bc288403f0056a94936cb014e8eb2.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99eac6dbdc6da138d553dc46d19d843b.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/660177a5eafcf9a75dcdc72559b45371.webp",980,1385]